SCHEMBL32688164

SCHEMBL32688164

COC(=O)Cc1cccc(CSc2[nH]c(=O)cc(-c3cccc(C(=O)Nc4ccccc4)c3)c2C#N)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.47
▸ POLB P06746 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ ACMSD Q8TDX5 5/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ ROCK2 O75116 1/20 0.40
▸ SIRT2 Q8IXJ6 3/20 0.40
▸ CFD P00746 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688394 0.92 NR1H4 (0.48) KMT2APOLBMEN1ACMSDALDH1A1
SCHEMBL32688012 0.90 ACMSD (0.49) KMT2APOLBMEN1ACMSDALDH1A1
SCHEMBL32688009 0.88 ACMSD (0.54) KMT2APOLBMEN1ACMSDALDH1A1
SCHEMBL32688277 0.87 KMT2A (0.52) KMT2APOLBMEN1ALDH1A1HPGD
SCHEMBL32688064 0.86 ACMSD (0.52) KMT2APOLBMEN1ACMSDALDH1A1
SCHEMBL32688124 0.83 ACMSD (0.42) KMT2APOLBMEN1ACMSDALDH1A1
SCHEMBL32688364 0.82 KMT2A (0.51) KMT2APOLBMEN1ALDH1A1HPGD
SCHEMBL20339582 0.80 KMT2A (0.64) KMT2APOLBMEN1ACMSDALDH1A1
SCHEMBL32688306 0.80 KMT2A (0.59) KMT2APOLBMEN1ACMSDALDH1A1
SCHEMBL32688271 0.79 ALDH1A1 (0.42) KMT2APOLBMEN1ACMSDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KMT2A 3400/4885POLB 508/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback